Anika Revised PMA For Orthovisc Osteoarthritis Treatment Slated For July
This article was originally published in The Gray Sheet
Executive Summary
Anika Therapeutics is pursuing a multiple-treatment indication for its Orthovisc sodium hyaluronic-acid (HA) injectable treatment for osteoarthritis of the knee, the firm reports.